Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ViruShield was a U.S.-based medical device and personal protective equipment company formed during the COVID-19 pandemic. The company marketed consumer-facing protective products including transparent respiratory shields and mask accessories intended to reduce viral exposure and improve usability versus standard cloth face coverings. Publicly available information indicates ViruShield focused on design-driven PPE rather than therapeutics, diagnostics, or a drug development pipeline. Its best-known product appears to have been the ViruShield Ghost, a reusable transparent face covering alternative. The company does not appear to be an active biotech, pharma, or broader life sciences drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ViruShield.